Fieldpoint Private Securities’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$0 Sell
5
-67
-93% -$5.53K ﹤0.01% 1741
2022
Q1
$6K Buy
72
+67
+1,340% +$6.42K ﹤0.01% 1250
2021
Q4
$1K Hold
5
﹤0.01% 1625
2021
Q3
$1K Sell
5
-52
-91% -$6.69K ﹤0.01% 1621
2021
Q2
$7K Buy
57
+52
+1,040% +$5.94K ﹤0.01% 1137
2021
Q1
$1K Hold
5
﹤0.01% 1539
2020
Q4
$1K Buy
+5
New +$470 ﹤0.01% 1467
2020
Q1
Sell
-53
Closed -$4K 582
2019
Q4
$4K Buy
+53
New +$4.13K ﹤0.01% 620
2018
Q3
Sell
-21
Closed -$1K 418
2018
Q2
$1K Hold
21
﹤0.01% 401
2018
Q1
$2K Hold
21
﹤0.01% 398
2017
Q4
$1K Sell
21
-984
-98% -$65.3K ﹤0.01% 387
2017
Q3
$63K Buy
+1,005
New +$60.1K 0.03% 348
2017
Q2
Sell
-234
Closed -$12K 335
2017
Q1
$12K Buy
+234
New +$11.4K 0.01% 302

Other funds holding XYL

Fieldpoint Private Securities's XYL Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Xylem (XYL) stake by 93% in Q2 2022, selling an estimated $5.53K and leaving 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Fieldpoint Private Securities first reported a position in XYL in Q1 2017 and has held it in 13 quarters since. The position peaked at $63K in Q3 2017. 725 funds tracked by Wall St. Rank hold XYL as of Q2 2022.

  • Fieldpoint Private Securities held 5 shares of Xylem worth $0 as of Q2 2022.
  • Fieldpoint Private Securities sold 67 Xylem shares in Q2 2022, an estimated $5.53K.
  • Xylem made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1741 holding.
  • Fieldpoint Private Securities first reported a position in Xylem in Q1 2017 and has held it in 13 quarters since.
  • Fieldpoint Private Securities's Xylem position peaked at $63K in Q3 2017.
  • 725 funds tracked by Wall St. Rank held Xylem as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.